Treatment of secondary injury after ischemic stroke through targeting microglia
Treatment of secondary injury after ischemic stroke through targeting microglia
批准号:
8573537
负责人:
Jaroslaw Aronowski
金额:
$33.25万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-07-01 至 2018-06-30
关键词:
AcuteAdultAffectAgonistAlteplaseAnti-Inflammatory AgentsAnti-inflammatoryBehavioralBiologicalBrainBrain InjuriesCellsCerebral IschemiaCessation of lifeCommunicationConditioned Culture MediaDataEligibility DeterminationEquilibriumEtiologyExcisionGenerationsHealedHematogenousIL4 geneIL4R geneImageIn VitroInfarctionInflammationInflammatoryInjection of therapeutic agentInjuryInterleukin-10Interleukin-13Interleukin-4IschemiaIschemic StrokeKnock-outLifeLigandsLinkMeasuresMediatingMessenger RNAMethodsMicrogliaModelingMolecular TargetMusNeuritesNeuronsOutcome MeasurePathway interactionsPatientsPeroxisome Proliferator-Activated ReceptorsPhagocytesPhagocytosisPhenotypePlayProcessProductionPropertyProteinsRXRReactive Oxygen SpeciesReceptor SignalingRecombinantsRecoveryRoleSTAT6 geneSecondary toSignal TransductionSourceStagingStressStrokeT-LymphocyteTNF geneTherapeuticTimeTissuesToxic effectTranslatingUnited Statesacute strokebasebrain cellbrain tissueclinically relevantcytokinecytotoxiccytotoxicitydisabilityeffective therapyfunctional outcomeshealingimprovedin vivoinjuredmacrophagemicrobicideneurological recoveryneutralizing antibodynovelpost strokepublic health relevancereceptorreceptor expressionrelating to nervous systemrepairedresearch studyresponsesensorstroke recoverytranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Though the activated microglia/macrophages (M¿) are known to contribute to secondary brain injury after stroke, M¿ are also instrumental in the repair process. To explain such contrasting roles, two M¿ phenotypes, "harmful"/M1 and "healing"/M2, have been proposed. Importantly, the M1 M¿ can be polarized to M2 and vice versa. While various molecules derived from stroke-injured cells have the propensity to polarize M¿ toward M1 type (causing the generation of pro-inflammatory cytokines and pro-oxidants), other molecules (e.g. generated by T cells), such as IL-4, IL10 or TGF¿, polarize M¿ toward the M2 type. The M2 M¿ control the cleanup processes (phagocytosis- mediated removal of toxic and pro-inflammatory cellular debris), and the production of trophic factors. Thus, the source of toxicity and the biological and physical barriers hampering neural reorganization are removed, while providing trophic support governing neuronal sprouting (the repair process). Without the M2 M¿, healing would not be possible. While both M1 and M2 M¿ phenotypes co-exist shortly after stroke, M2 phenotype weakens within 2-3 days allowing M1 type to dominate. This adversely affects the brain cleanup, repair, and recovery, while boosting cytotoxicity. Exploring the mechanisms underlying such processes and therapeutic approaches aiming at rectifying the M2 polarization loss are the subjects of this proposal. Our novel findings indicate that in response to ischemia, neurons synthesize and release IL-4 (canonical M2 polarizing cytokine) during the first 3 days of stroke, followed by a decline in both IL-4 and M2 M¿ levels. IL-4-induced M2 M¿ polarization requires the activation of RXR-PPAR? pathway. The administration of IL-4 or agonists of PPAR? and RXR (rectifying factors) for 5 days, starting at 1d post stroke, improves recovery and neuronal re-wiring. Loss of PPAR? in M¿ impedes recovery. Aim 1. Elucidate, in vitro, the role of neurons in M¿ polarization and post stroke repair: IL-4- medaited PPAR?:RXR-executed process involving phagocytosis (cleanup) and trophic stimulation. Hypothesis: Neurons act as sensors of "injury" and generate IL-4/IL13 that signals to microglia to induce M2 polarization, while suppressing M1 phenotype associated with cytotoxicity. Aim 2. Elucidate, in vivo, the basis of IL-4 signaling to PPAR?:RXR, and apply them into clinically relevant approaches targeting the phagocyte-mediated brain cleanup, remodeling, and post- stroke recovery. Hypothesis: Because the initial polarization toward the "healing" M¿ phenotype after stroke, driven by neuronal production of IL4/IL13, is lost within few days after stroke, approaches aiming at restoring IL-4-medaited signaling, such as via recombinant IL-4 and PPAR?:RXR activation (molecular targets of IL-4 in M¿), to rectify M2 polarization loss will assist in post stroke recovery.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Aryl hydrocarbon receptor and bilirubin as therapeutic target for ICH
-
批准号:10615880
-
项目类别:
-
资助金额:$47.13万
-
财政年份:2021
-
负责人:Jaroslaw Aronowski
-
依托单位:
Aryl hydrocarbon receptor and bilirubin as therapeutic target for ICH
-
批准号:10299427
-
项目类别:
-
资助金额:$46.49万
-
财政年份:2021
-
负责人:Jaroslaw Aronowski
-
依托单位:
Aryl hydrocarbon receptor and bilirubin as therapeutic target for ICH
-
批准号:10408850
-
项目类别:
-
资助金额:$47.13万
-
财政年份:2021
-
负责人:Jaroslaw Aronowski
-
依托单位:
Humanin and Intracerebral Hemorrhage
-
批准号:10316990
-
项目类别:
-
资助金额:$47.05万
-
财政年份:2019
-
负责人:Jaroslaw Aronowski
-
依托单位:
Humanin and Intracerebral Hemorrhage
-
批准号:10547749
-
项目类别:
-
资助金额:$47.05万
-
财政年份:2019
-
负责人:Jaroslaw Aronowski
-
依托单位:
Stroke Preclinical Assessment Network (SPAN) – Tacilizumab for treatment of acute ischemic stroke
-
批准号:10214711
-
项目类别:
-
资助金额:$50.69万
-
财政年份:2019
-
负责人:Jaroslaw Aronowski
-
依托单位:
Neutrophils in Recovery after ICH
-
批准号:9816107
-
项目类别:
-
资助金额:$7.37万
-
财政年份:2016
-
负责人:Jaroslaw Aronowski
-
依托单位:
Optimized lactoferrin for treatment of intracerebral hemorrhage
-
批准号:9016473
-
项目类别:
-
资助金额:$4.76万
-
财政年份:2015
-
负责人:Jaroslaw Aronowski
-
依托单位:
Optimized lactoferrin for treatment of intracerebral hemorrhage
-
批准号:9248446
-
项目类别:
-
资助金额:$82.75万
-
财政年份:2014
-
负责人:Jaroslaw Aronowski
-
依托单位:
Optimized lactoferrin for treatment of intracerebral hemorrhage
-
批准号:8831091
-
项目类别:
-
资助金额:$18.91万
-
财政年份:2014
-
负责人:Jaroslaw Aronowski
-
依托单位:
Treatment of secondary injury after ischemic stroke through targeting microglia
-
批准号:8658499
-
项目类别:
-
资助金额:$32.92万
-
财政年份:2013
-
负责人:Jaroslaw Aronowski
-
依托单位:
Treatment of secondary injury after ischemic stroke through targeting microglia
-
批准号:9282508
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2013
-
负责人:Jaroslaw Aronowski
-
依托单位:
Treatment of secondary injury after ischemic stroke through targeting microglia
-
批准号:8865726
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2013
-
负责人:Jaroslaw Aronowski
-
依托单位:
Pleiotropic Transcription Factors As Target For Intracerebral Hemorrhage Treatmen
-
批准号:8268554
-
项目类别:
-
资助金额:$32.16万
-
财政年份:2008
-
负责人:Jaroslaw Aronowski
-
依托单位:
Pleiotropic Transcription Factors As Target For Intracerebral Hemorrhage Treatmen
-
批准号:8077211
-
项目类别:
-
资助金额:$32.16万
-
财政年份:2008
-
负责人:Jaroslaw Aronowski
-
依托单位:
Pleiotropic Transcription Factors As Target For Intracerebral Hemorrhage Treatmen
-
批准号:7844990
-
项目类别:
-
资助金额:$32.48万
-
财政年份:2008
-
负责人:Jaroslaw Aronowski
-
依托单位:
Pleiotropic Transcription Factors As Target For Intracerebral Hemorrhage Treatmen
-
批准号:7526910
-
项目类别:
-
资助金额:$32.79万
-
财政年份:2008
-
负责人:Jaroslaw Aronowski
-
依托单位:
Pleiotropic Transcription Factors As Target For Intracerebral Hemorrhage Treatmen
-
批准号:7662255
-
项目类别:
-
资助金额:$32.81万
-
财政年份:2008
-
负责人:Jaroslaw Aronowski
-
依托单位:
New Target For Stroke: Peroxisome Proliferator Activated Receptor-Gamma
-
批准号:7105933
-
项目类别:
-
资助金额:$29.7万
-
财政年份:2006
-
负责人:Jaroslaw Aronowski
-
依托单位:
New Target For Stroke: Peroxisome Proliferator Activated Receptor-Gamma
-
批准号:7409751
-
项目类别:
-
资助金额:$28.84万
-
财政年份:2006
-
负责人:Jaroslaw Aronowski
-
依托单位:
海外基金